Owkin 推出 K Pro：首個由生物推理模型驅動的生物製藥智能 AI 協作助手
Oct 16, 2025 14:00 HKT |  |
|
Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models
Oct 16, 2025 13:00 HKT | |
|
Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14
Oct 14, 2025 17:38 HKT |  |
|
雲頂新耀EVM14全球臨床穩步推進 中美IND「雙獲批」後美國首例患者成功入組
Oct 14, 2025 17:32 HKT | |
|
云顶新耀EVM14全球临床稳步推进 中美IND"双获批"后美国首例患者成功入组
Oct 14, 2025 17:13 HKT | |
|
康基医疗与Knight Bidco联合发布私有化建议计划文件
Oct 13, 2025 10:14 HKT | |
|
Kangji Medical and Knight Bidco Jointly Dispatch Scheme Document for Privatisation Proposal
Oct 13, 2025 10:14 HKT | |
|
康基醫療與Knight Bidco聯合發佈私有化建議計劃文件
Oct 13, 2025 10:14 HKT | |
|
?????????????????ENLIGHT UC??(ES101002)????????? ??????????????????
Oct 09, 2025 18:24 HKT | |
|
雲頂新耀艾曲莫德亞洲多中心Ⅲ期臨床ENLIGHT UC研究（ES101002）結果榮登柳葉刀子刊 展示在亞洲患者中的突破性療效與安全性
Oct 09, 2025 18:24 HKT | |
|
Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology
Oct 09, 2025 18:24 HKT | |
|
华领医药宣布中国香港卫生署药物办公室正式受理多格列艾汀新药上市许可申请
Sep 29, 2025 11:22 HKT |  |
|
華領醫藥宣佈中國香港衛生署藥物辦公室正式受理多格列艾汀新藥上市許可申請
Sep 29, 2025 11:22 HKT | |
|
Hua Medicine Announces the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin
Sep 29, 2025 11:22 HKT | |
|
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
Sep 28, 2025 15:00 HKT |  |
|
康哲药业（867.HK；8A8.SG）创新药磷酸芦可替尼乳膏AD中国三期临床取得积极结果
Sep 28, 2025 11:33 HKT | |
|
康哲藥業（867.HK；8A8.SG）創新藥磷酸蘆可替尼乳膏AD中國三期臨床取得積極結果
Sep 28, 2025 11:33 HKT | |
|
心肾代谢综合征（CKM）治疗的新范式 君圣泰的"一药多效"迎来价值重估
Sep 23, 2025 21:53 HKT |  |
|
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies
Sep 23, 2025 12:15 HKT | |
|
康哲药业就用于破伤风被动免疫和狂犬病被动免疫的两款创新生物制剂达成合作
Sep 23, 2025 11:16 HKT | |
|